Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCloudtag Inc Regulatory News (CTAG)

  • There is currently no data for CTAG

Executive Director Appointment

8 Jan 2015 07:00

RNS Number : 6024B
CloudTag Inc.
08 January 2015
 



8 January 2015

CloudTag Inc.("CloudTag" or the "Company")

Appointment of Director of Corporate Development

CloudTag (CTAG:LN), which develops personal performance monitoring for the professional sports and consumer wellbeing markets, is pleased to announce that it has appointed Amit Ben-Haim as Director of Corporate Development with immediate effect.

 

CloudTag has appointed Amit as an Executive Director of the Company on a full-time basis, to reflect the true potential of his contribution going forward in the next phase of the Company's development. Amit will be involved in the on-going growth, development and expansion of the Company, both on a commercial and corporate basis.

 

Prior to this appointment, Amit was engaged as a Consultant to CloudTag, making introductions to investors and other partners in the areas of finance, technology and consumer health and wellbeing. He has a proven track record as a successful entrepreneur establishing, leading and expanding companies through to trade sale exits as co-founder, executive and non-executive director. In 1993, he co-founded Biosense Inc., a medical devices company which was sold to Dow Jones-listed Johnson & Johnson in 1997 for $485 million. In 1996, he co-established Impulse Dynamics Inc., another medical devices company, which ultimately licensed its cardiac contractility technology to NYSE-listed Guidant Corporation and in 1998 he was one of several founders of Odigo Inc., a communications company specialising in instant messaging platforms, which was sold in 2000 to NASDAQ-listed Comverse Inc.

 

Pursuant to Rule 17 and Schedule 2 paragraph (g) of the AIM Rules for Companies, the following information is disclosed:

 

Amit Ben-Haim, aged 54, is or has been a director or member of the following companies or partnerships during the previous five years:

Current Directorships or Partnerships

 

Past Directorships within the last 5 years

 

SB Corporate Finance Partners Limited

 

Balfour Electronics Limited

Essentium Group Limited

Golden Bridge Services Limited

Novum Wines Limited

 

Mr Ben-Haim is interested in 6,666,667 ordinary shares of 0.25p each in the Company, representing 4.02% of the issued share capital of the Company. There is no further information to be disclosed pursuant to Schedule 2 paragraph (g) of the AIM Rules for Companies.

 

Commenting, Tony Reeves, Non-Executive Chairman: "I am delighted that Amit has agreed to join the Board of Directors and we look forward to him becoming an integral part of the business going forward."

 

Enquiries

CloudTag Inc.

Andy Jackson / Mike Hirschfield

 

+44(0) 20 3740 7464 contact@cloudtag.com

Cairn Financial Advisors LLP (Nominated Adviser)

Avi Robinson / Paul Trendell

+44 (0) 20 7148 7900

Gable Communications Limited

John Bick

+44 (0) 20 7193 7463

cloudtag@gablecommunications.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASSDEDWFISELF
Date   Source Headline
5th Sep 201611:00 amRNSSecond Price Monitoring Extn
5th Sep 20169:05 amRNSSecond Price Monitoring Extn
5th Sep 20169:00 amRNSPrice Monitoring Extension
2nd Sep 20164:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20164:35 pmRNSPrice Monitoring Extension
2nd Sep 20164:02 pmRNSMovement in Share Price and Update
16th Aug 201611:16 amRNSHolding(s) in Company
10th Aug 20167:00 amRNSFundraise of £580,000
8th Aug 20167:00 amRNSBinding Heads of Terms Signed with US Partner
5th Aug 20161:28 pmRNSCorrection: Holding(s) in Company
4th Aug 20164:08 pmRNSHolding(s) in Company
1st Aug 20167:00 amRNSAppointment of Chief Creative Officer
18th Jul 20165:13 pmRNSHolding(s) in Company
14th Jul 201611:32 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSFundraise of £800,000
12th Jul 20167:00 amRNSIssue of Equity
6th Jul 20167:00 amRNSGrant of Options and Warrants
5th Jul 20164:40 pmRNSSecond Price Monitoring Extn
5th Jul 20164:35 pmRNSPrice Monitoring Extension
1st Jul 20164:10 pmRNSHolding(s) in Company
28th Jun 20167:00 amRNSHalf-year Report
22nd Jun 20161:10 pmRNSHolding(s) in Company
16th Jun 20167:00 amRNSOperational Update & Subscription for £470,000
15th Jun 20164:21 pmRNSHolding(s) in Company
9th Jun 20167:00 amRNSCommercial Update and Subscription
31st May 201610:07 amRNSMovement in Share Price
10th May 201610:06 amRNSHolding(s) in Company
3rd May 20167:00 amRNSFundraising £50,000 & Conversion of Loan Notes
29th Apr 20164:48 pmRNSIssue of Equity
26th Apr 20164:03 pmRNSResult of AGM
12th Apr 20163:59 pmRNSCorrection: Fundraise of £171,430
11th Apr 20167:00 amRNSFundraise of £171,430
7th Apr 20164:58 pmRNSHolding(s) in Company
5th Apr 20166:01 pmRNSFundraise of £60,000
31st Mar 20167:00 amRNSHolding(s) in Company
30th Mar 20165:23 pmRNSPosting of Annual Report
30th Mar 20167:00 amRNSDirector/PDMR Shareholding
24th Mar 20167:00 amRNSFundraise of £112,000
23rd Mar 20167:00 amRNSFinal Results
21st Mar 20167:00 amRNSFundraise of £225,400
16th Mar 201611:03 amRNSFundraise of £228,000
16th Mar 20169:28 amRNSHolding(s) in Company
7th Mar 20167:00 amRNSFundraise of £65,000
29th Feb 20164:19 pmRNS£215,000 Fundraising
25th Jan 20167:00 amRNSUS$5.2 Million Distribution Agreement
22nd Jan 20167:00 amRNSISPO Exhibition
21st Jan 20167:00 amRNS£250,000 Fundraising
15th Jan 20167:00 amRNSOperational Update & Convertible Loan Facility
6th Jan 20168:03 amRNSFirst Product Launch
31st Dec 20157:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.